PubMed:32023685 JSONTXT

{"project":"LitCovid-PAS-Enju","denotations":[{"id":"EnjuParser_T0","span":{"begin":0,"end":1},"obj":"-LRB-"},{"id":"EnjuParser_T1","span":{"begin":1,"end":10},"obj":"JJ"},{"id":"EnjuParser_T2","span":{"begin":11,"end":20},"obj":"JJ"},{"id":"EnjuParser_T3","span":{"begin":21,"end":33},"obj":"NNS"},{"id":"EnjuParser_T4","span":{"begin":34,"end":37},"obj":"IN"},{"id":"EnjuParser_T5","span":{"begin":38,"end":42},"obj":"CD"},{"id":"EnjuParser_T6","span":{"begin":43,"end":48},"obj":"NNP"},{"id":"EnjuParser_T7","span":{"begin":49,"end":60},"obj":"NNP"},{"id":"EnjuParser_T8","span":{"begin":60,"end":61},"obj":"-RRB-"},{"id":"EnjuParser_T9","span":{"begin":63,"end":66},"obj":"DT"},{"id":"EnjuParser_T10","span":{"begin":67,"end":73},"obj":"JJ"},{"id":"EnjuParser_T11","span":{"begin":74,"end":82},"obj":"NN"},{"id":"EnjuParser_T12","span":{"begin":83,"end":85},"obj":"IN"},{"id":"EnjuParser_T13","span":{"begin":86,"end":97},"obj":"JJ"},{"id":"EnjuParser_T14","span":{"begin":98,"end":105},"obj":"NN"},{"id":"EnjuParser_T15","span":{"begin":106,"end":108},"obj":"IN"},{"id":"EnjuParser_T16","span":{"begin":109,"end":114},"obj":"NNP"},{"id":"EnjuParser_T17","span":{"begin":114,"end":115},"obj":"-COMMA-"},{"id":"EnjuParser_T18","span":{"begin":116,"end":121},"obj":"NNP"},{"id":"EnjuParser_T19","span":{"begin":122,"end":124},"obj":"VBZ"},{"id":"EnjuParser_T20","span":{"begin":125,"end":131},"obj":"VBN"},{"id":"EnjuParser_T21","span":{"begin":132,"end":134},"obj":"IN"},{"id":"EnjuParser_T22","span":{"begin":135,"end":136},"obj":"DT"},{"id":"EnjuParser_T23","span":{"begin":137,"end":142},"obj":"JJ"},{"id":"EnjuParser_T24","span":{"begin":143,"end":154},"obj":"NN"},{"id":"EnjuParser_T25","span":{"begin":154,"end":155},"obj":"-COMMA-"},{"id":"EnjuParser_T26","span":{"begin":156,"end":161},"obj":"VBN"},{"id":"EnjuParser_T27","span":{"begin":162,"end":171},"obj":"NN"},{"id":"EnjuParser_T28","span":{"begin":171,"end":172},"obj":"-COMMA-"},{"id":"EnjuParser_T29","span":{"begin":173,"end":178},"obj":"WDT"},{"id":"EnjuParser_T30","span":{"begin":179,"end":181},"obj":"VBZ"},{"id":"EnjuParser_T31","span":{"begin":182,"end":193},"obj":"RB"},{"id":"EnjuParser_T32","span":{"begin":194,"end":199},"obj":"RB"},{"id":"EnjuParser_T33","span":{"begin":200,"end":202},"obj":"TO"},{"id":"EnjuParser_T34","span":{"begin":203,"end":204},"obj":"DT"},{"id":"EnjuParser_T35","span":{"begin":205,"end":216},"obj":"JJ"},{"id":"EnjuParser_T36","span":{"begin":217,"end":228},"obj":"NN"},{"id":"EnjuParser_T37","span":{"begin":230,"end":239},"obj":"NN"},{"id":"EnjuParser_T38","span":{"begin":240,"end":242},"obj":"VBZ"},{"id":"EnjuParser_T39","span":{"begin":243,"end":254},"obj":"VBN"},{"id":"EnjuParser_T40","span":{"begin":255,"end":257},"obj":"IN"},{"id":"EnjuParser_T41","span":{"begin":258,"end":262},"obj":"SYM"},{"id":"EnjuParser_T42","span":{"begin":263,"end":268},"obj":"NN"},{"id":"EnjuParser_T43","span":{"begin":269,"end":280},"obj":"NN"},{"id":"EnjuParser_T44","span":{"begin":280,"end":281},"obj":"-COMMA-"},{"id":"EnjuParser_T45","span":{"begin":282,"end":286},"obj":"JJ"},{"id":"EnjuParser_T46","span":{"begin":287,"end":289},"obj":"IN"},{"id":"EnjuParser_T47","span":{"begin":290,"end":293},"obj":"DT"},{"id":"EnjuParser_T48","span":{"begin":294,"end":297},"obj":"CD"},{"id":"EnjuParser_T49","span":{"begin":298,"end":303},"obj":"JJ"},{"id":"EnjuParser_T50","span":{"begin":304,"end":311},"obj":"NNS"},{"id":"EnjuParser_T51","span":{"begin":312,"end":313},"obj":"-COLON-"},{"id":"EnjuParser_T52","span":{"begin":314,"end":320},"obj":"JJ"},{"id":"EnjuParser_T53","span":{"begin":321,"end":326},"obj":"JJ"},{"id":"EnjuParser_T54","span":{"begin":327,"end":338},"obj":"JJ"},{"id":"EnjuParser_T55","span":{"begin":339,"end":347},"obj":"NN"},{"id":"EnjuParser_T56","span":{"begin":348,"end":359},"obj":"NN"},{"id":"EnjuParser_T57","span":{"begin":360,"end":361},"obj":"-LRB-"},{"id":"EnjuParser_T58","span":{"begin":361,"end":369},"obj":"NN"},{"id":"EnjuParser_T59","span":{"begin":369,"end":370},"obj":"-RRB-"},{"id":"EnjuParser_T60","span":{"begin":371,"end":374},"obj":"CC"},{"id":"EnjuParser_T61","span":{"begin":375,"end":381},"obj":"NNP"},{"id":"EnjuParser_T62","span":{"begin":382,"end":386},"obj":"NNP"},{"id":"EnjuParser_T63","span":{"begin":387,"end":398},"obj":"JJ"},{"id":"EnjuParser_T64","span":{"begin":399,"end":407},"obj":"NN"},{"id":"EnjuParser_T65","span":{"begin":408,"end":419},"obj":"NN"},{"id":"EnjuParser_T66","span":{"begin":420,"end":421},"obj":"-LRB-"},{"id":"EnjuParser_T67","span":{"begin":421,"end":429},"obj":"NN"},{"id":"EnjuParser_T68","span":{"begin":429,"end":430},"obj":"-RRB-"},{"id":"EnjuParser_T69","span":{"begin":432,"end":441},"obj":"JJ"},{"id":"EnjuParser_T70","span":{"begin":442,"end":447},"obj":"NNS"},{"id":"EnjuParser_T71","span":{"begin":448,"end":456},"obj":"RB"},{"id":"EnjuParser_T72","span":{"begin":457,"end":461},"obj":"VBN"},{"id":"EnjuParser_T73","span":{"begin":462,"end":464},"obj":"IN"},{"id":"EnjuParser_T74","span":{"begin":465,"end":473},"obj":"JJ"},{"id":"EnjuParser_T75","span":{"begin":474,"end":482},"obj":"NN"},{"id":"EnjuParser_T76","span":{"begin":482,"end":483},"obj":"-COMMA-"},{"id":"EnjuParser_T77","span":{"begin":484,"end":493},"obj":"VBG"},{"id":"EnjuParser_T78","span":{"begin":494,"end":507},"obj":"NN"},{"id":"EnjuParser_T79","span":{"begin":508,"end":518},"obj":"NNS"},{"id":"EnjuParser_T80","span":{"begin":519,"end":520},"obj":"-LRB-"},{"id":"EnjuParser_T81","span":{"begin":520,"end":531},"obj":"NN"},{"id":"EnjuParser_T82","span":{"begin":531,"end":532},"obj":"-COMMA-"},{"id":"EnjuParser_T83","span":{"begin":533,"end":542},"obj":"NN"},{"id":"EnjuParser_T84","span":{"begin":542,"end":543},"obj":"-COMMA-"},{"id":"EnjuParser_T85","span":{"begin":544,"end":553},"obj":"NN"},{"id":"EnjuParser_T86","span":{"begin":553,"end":554},"obj":"-COMMA-"},{"id":"EnjuParser_T87","span":{"begin":555,"end":559},"obj":"FW"},{"id":"EnjuParser_T88","span":{"begin":559,"end":560},"obj":"-RRB-"},{"id":"EnjuParser_T89","span":{"begin":560,"end":561},"obj":"-COMMA-"},{"id":"EnjuParser_T90","span":{"begin":562,"end":573},"obj":"NN"},{"id":"EnjuParser_T91","span":{"begin":573,"end":574},"obj":"-COMMA-"},{"id":"EnjuParser_T92","span":{"begin":575,"end":584},"obj":"NN"},{"id":"EnjuParser_T93","span":{"begin":585,"end":588},"obj":"CC"},{"id":"EnjuParser_T94","span":{"begin":589,"end":598},"obj":"NN"},{"id":"EnjuParser_T95","span":{"begin":598,"end":599},"obj":"-COMMA-"},{"id":"EnjuParser_T96","span":{"begin":600,"end":603},"obj":"VBP"},{"id":"EnjuParser_T97","span":{"begin":604,"end":611},"obj":"JJ"},{"id":"EnjuParser_T98","span":{"begin":612,"end":615},"obj":"IN"},{"id":"EnjuParser_T99","span":{"begin":616,"end":625},"obj":"NN"},{"id":"EnjuParser_T100","span":{"begin":626,"end":629},"obj":"CC"},{"id":"EnjuParser_T101","span":{"begin":630,"end":633},"obj":"RB"},{"id":"EnjuParser_T102","span":{"begin":634,"end":645},"obj":"VBN"},{"id":"EnjuParser_T103","span":{"begin":647,"end":652},"obj":"NNS"},{"id":"EnjuParser_T104","span":{"begin":653,"end":656},"obj":"VBP"},{"id":"EnjuParser_T105","span":{"begin":657,"end":665},"obj":"RB"},{"id":"EnjuParser_T106","span":{"begin":666,"end":675},"obj":"JJ"},{"id":"EnjuParser_T107","span":{"begin":676,"end":679},"obj":"IN"},{"id":"EnjuParser_T108","span":{"begin":680,"end":689},"obj":"NN"},{"id":"EnjuParser_T109","span":{"begin":690,"end":697},"obj":"VBP"},{"id":"EnjuParser_T110","span":{"begin":697,"end":698},"obj":"-COLON-"},{"id":"EnjuParser_T111","span":{"begin":699,"end":709},"obj":"NN"},{"id":"EnjuParser_T112","span":{"begin":709,"end":710},"obj":"-COMMA-"},{"id":"EnjuParser_T113","span":{"begin":711,"end":720},"obj":"NN"},{"id":"EnjuParser_T114","span":{"begin":721,"end":722},"obj":"SYM"},{"id":"EnjuParser_T115","span":{"begin":723,"end":732},"obj":"NN"},{"id":"EnjuParser_T116","span":{"begin":732,"end":733},"obj":"-COMMA-"},{"id":"EnjuParser_T117","span":{"begin":734,"end":743},"obj":"NN"},{"id":"EnjuParser_T118","span":{"begin":744,"end":745},"obj":"SYM"},{"id":"EnjuParser_T119","span":{"begin":746,"end":755},"obj":"NN"},{"id":"EnjuParser_T120","span":{"begin":756,"end":764},"obj":"VBN"},{"id":"EnjuParser_T121","span":{"begin":765,"end":769},"obj":"IN"},{"id":"EnjuParser_T122","span":{"begin":770,"end":782},"obj":"NN"},{"id":"EnjuParser_T123","span":{"begin":782,"end":783},"obj":"-COMMA-"},{"id":"EnjuParser_T124","span":{"begin":784,"end":796},"obj":"JJ"},{"id":"EnjuParser_T125","span":{"begin":797,"end":803},"obj":"NN"},{"id":"EnjuParser_T126","span":{"begin":803,"end":804},"obj":"-COMMA-"},{"id":"EnjuParser_T127","span":{"begin":805,"end":808},"obj":"CC"},{"id":"EnjuParser_T128","span":{"begin":809,"end":819},"obj":"JJ"},{"id":"EnjuParser_T129","span":{"begin":820,"end":830},"obj":"NNS"},{"id":"EnjuParser_T130","span":{"begin":832,"end":835},"obj":"CC"},{"id":"EnjuParser_T131","span":{"begin":836,"end":839},"obj":"DT"},{"id":"EnjuParser_T132","span":{"begin":840,"end":848},"obj":"NN"},{"id":"EnjuParser_T133","span":{"begin":849,"end":852},"obj":"CC"},{"id":"EnjuParser_T134","span":{"begin":853,"end":859},"obj":"NN"},{"id":"EnjuParser_T135","span":{"begin":860,"end":862},"obj":"IN"},{"id":"EnjuParser_T136","span":{"begin":863,"end":868},"obj":"DT"},{"id":"EnjuParser_T137","span":{"begin":869,"end":874},"obj":"NNS"},{"id":"EnjuParser_T138","span":{"begin":875,"end":878},"obj":"IN"},{"id":"EnjuParser_T139","span":{"begin":879,"end":888},"obj":"JJ"},{"id":"EnjuParser_T140","span":{"begin":889,"end":898},"obj":"NN"},{"id":"EnjuParser_T141","span":{"begin":899,"end":907},"obj":"NNS"},{"id":"EnjuParser_T142","span":{"begin":908,"end":912},"obj":"VBP"},{"id":"EnjuParser_T143","span":{"begin":913,"end":915},"obj":"TO"},{"id":"EnjuParser_T144","span":{"begin":916,"end":918},"obj":"VB"},{"id":"EnjuParser_T145","span":{"begin":919,"end":927},"obj":"VBN"},{"id":"EnjuParser_T146","span":{"begin":928,"end":930},"obj":"IN"},{"id":"EnjuParser_T147","span":{"begin":931,"end":938},"obj":"JJ"},{"id":"EnjuParser_T148","span":{"begin":939,"end":947},"obj":"JJ"},{"id":"EnjuParser_T149","span":{"begin":948,"end":954},"obj":"NNS"}],"relations":[{"id":"EnjuParser_R0","pred":"arg1Of","subj":"EnjuParser_T3","obj":"EnjuParser_T0"},{"id":"EnjuParser_R1","pred":"arg1Of","subj":"EnjuParser_T3","obj":"EnjuParser_T1"},{"id":"EnjuParser_R2","pred":"arg1Of","subj":"EnjuParser_T3","obj":"EnjuParser_T2"},{"id":"EnjuParser_R3","pred":"arg1Of","subj":"EnjuParser_T3","obj":"EnjuParser_T4"},{"id":"EnjuParser_R4","pred":"arg2Of","subj":"EnjuParser_T7","obj":"EnjuParser_T4"},{"id":"EnjuParser_R5","pred":"arg1Of","subj":"EnjuParser_T7","obj":"EnjuParser_T5"},{"id":"EnjuParser_R6","pred":"arg1Of","subj":"EnjuParser_T7","obj":"EnjuParser_T6"},{"id":"EnjuParser_R7","pred":"arg1Of","subj":"EnjuParser_T3","obj":"EnjuParser_T8"},{"id":"EnjuParser_R8","pred":"arg1Of","subj":"EnjuParser_T11","obj":"EnjuParser_T9"},{"id":"EnjuParser_R9","pred":"arg1Of","subj":"EnjuParser_T11","obj":"EnjuParser_T10"},{"id":"EnjuParser_R10","pred":"arg1Of","subj":"EnjuParser_T11","obj":"EnjuParser_T12"},{"id":"EnjuParser_R11","pred":"arg2Of","subj":"EnjuParser_T14","obj":"EnjuParser_T12"},{"id":"EnjuParser_R12","pred":"arg1Of","subj":"EnjuParser_T14","obj":"EnjuParser_T13"},{"id":"EnjuParser_R13","pred":"arg1Of","subj":"EnjuParser_T14","obj":"EnjuParser_T15"},{"id":"EnjuParser_R14","pred":"arg2Of","subj":"EnjuParser_T16","obj":"EnjuParser_T15"},{"id":"EnjuParser_R15","pred":"arg1Of","subj":"EnjuParser_T16","obj":"EnjuParser_T17"},{"id":"EnjuParser_R16","pred":"arg2Of","subj":"EnjuParser_T18","obj":"EnjuParser_T17"},{"id":"EnjuParser_R17","pred":"arg1Of","subj":"EnjuParser_T11","obj":"EnjuParser_T19"},{"id":"EnjuParser_R18","pred":"arg2Of","subj":"EnjuParser_T20","obj":"EnjuParser_T19"},{"id":"EnjuParser_R19","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T20"},{"id":"EnjuParser_R20","pred":"arg2Of","subj":"EnjuParser_T11","obj":"EnjuParser_T20"},{"id":"EnjuParser_R21","pred":"arg2Of","subj":"EnjuParser_T24","obj":"EnjuParser_T21"},{"id":"EnjuParser_R22","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T22"},{"id":"EnjuParser_R23","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T23"},{"id":"EnjuParser_R24","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T25"},{"id":"EnjuParser_R25","pred":"arg2Of","subj":"EnjuParser_T24","obj":"EnjuParser_T26"},{"id":"EnjuParser_R26","pred":"arg3Of","subj":"EnjuParser_T27","obj":"EnjuParser_T26"},{"id":"EnjuParser_R27","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T28"},{"id":"EnjuParser_R28","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T29"},{"id":"EnjuParser_R29","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T30"},{"id":"EnjuParser_R30","pred":"arg2Of","subj":"EnjuParser_T32","obj":"EnjuParser_T30"},{"id":"EnjuParser_R31","pred":"arg1Of","subj":"EnjuParser_T32","obj":"EnjuParser_T31"},{"id":"EnjuParser_R32","pred":"arg1Of","subj":"EnjuParser_T24","obj":"EnjuParser_T32"},{"id":"EnjuParser_R33","pred":"arg1Of","subj":"EnjuParser_T32","obj":"EnjuParser_T33"},{"id":"EnjuParser_R34","pred":"arg2Of","subj":"EnjuParser_T36","obj":"EnjuParser_T33"},{"id":"EnjuParser_R35","pred":"arg1Of","subj":"EnjuParser_T36","obj":"EnjuParser_T34"},{"id":"EnjuParser_R36","pred":"arg1Of","subj":"EnjuParser_T36","obj":"EnjuParser_T35"},{"id":"EnjuParser_R37","pred":"arg1Of","subj":"EnjuParser_T37","obj":"EnjuParser_T38"},{"id":"EnjuParser_R38","pred":"arg2Of","subj":"EnjuParser_T39","obj":"EnjuParser_T38"},{"id":"EnjuParser_R39","pred":"arg2Of","subj":"EnjuParser_T37","obj":"EnjuParser_T39"},{"id":"EnjuParser_R40","pred":"arg1Of","subj":"EnjuParser_T39","obj":"EnjuParser_T40"},{"id":"EnjuParser_R41","pred":"arg2Of","subj":"EnjuParser_T43","obj":"EnjuParser_T40"},{"id":"EnjuParser_R42","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T41"},{"id":"EnjuParser_R43","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T42"},{"id":"EnjuParser_R44","pred":"arg1Of","subj":"EnjuParser_T39","obj":"EnjuParser_T44"},{"id":"EnjuParser_R45","pred":"arg1Of","subj":"EnjuParser_T39","obj":"EnjuParser_T45"},{"id":"EnjuParser_R46","pred":"arg1Of","subj":"EnjuParser_T45","obj":"EnjuParser_T46"},{"id":"EnjuParser_R47","pred":"arg2Of","subj":"EnjuParser_T50","obj":"EnjuParser_T46"},{"id":"EnjuParser_R48","pred":"arg1Of","subj":"EnjuParser_T50","obj":"EnjuParser_T47"},{"id":"EnjuParser_R49","pred":"arg1Of","subj":"EnjuParser_T50","obj":"EnjuParser_T48"},{"id":"EnjuParser_R50","pred":"arg1Of","subj":"EnjuParser_T50","obj":"EnjuParser_T49"},{"id":"EnjuParser_R51","pred":"arg1Of","subj":"EnjuParser_T50","obj":"EnjuParser_T51"},{"id":"EnjuParser_R52","pred":"arg2Of","subj":"EnjuParser_T60","obj":"EnjuParser_T51"},{"id":"EnjuParser_R53","pred":"arg1Of","subj":"EnjuParser_T54","obj":"EnjuParser_T52"},{"id":"EnjuParser_R54","pred":"arg1Of","subj":"EnjuParser_T54","obj":"EnjuParser_T53"},{"id":"EnjuParser_R55","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T54"},{"id":"EnjuParser_R56","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T55"},{"id":"EnjuParser_R57","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T57"},{"id":"EnjuParser_R58","pred":"arg2Of","subj":"EnjuParser_T58","obj":"EnjuParser_T57"},{"id":"EnjuParser_R59","pred":"arg3Of","subj":"EnjuParser_T59","obj":"EnjuParser_T57"},{"id":"EnjuParser_R60","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T60"},{"id":"EnjuParser_R61","pred":"arg2Of","subj":"EnjuParser_T65","obj":"EnjuParser_T60"},{"id":"EnjuParser_R62","pred":"arg1Of","subj":"EnjuParser_T62","obj":"EnjuParser_T61"},{"id":"EnjuParser_R63","pred":"arg1Of","subj":"EnjuParser_T65","obj":"EnjuParser_T62"},{"id":"EnjuParser_R64","pred":"arg1Of","subj":"EnjuParser_T65","obj":"EnjuParser_T63"},{"id":"EnjuParser_R65","pred":"arg1Of","subj":"EnjuParser_T65","obj":"EnjuParser_T64"},{"id":"EnjuParser_R66","pred":"arg1Of","subj":"EnjuParser_T65","obj":"EnjuParser_T66"},{"id":"EnjuParser_R67","pred":"arg2Of","subj":"EnjuParser_T67","obj":"EnjuParser_T66"},{"id":"EnjuParser_R68","pred":"arg3Of","subj":"EnjuParser_T68","obj":"EnjuParser_T66"},{"id":"EnjuParser_R69","pred":"arg1Of","subj":"EnjuParser_T70","obj":"EnjuParser_T69"},{"id":"EnjuParser_R70","pred":"arg1Of","subj":"EnjuParser_T72","obj":"EnjuParser_T71"},{"id":"EnjuParser_R71","pred":"arg2Of","subj":"EnjuParser_T70","obj":"EnjuParser_T72"},{"id":"EnjuParser_R72","pred":"arg1Of","subj":"EnjuParser_T72","obj":"EnjuParser_T73"},{"id":"EnjuParser_R73","pred":"arg2Of","subj":"EnjuParser_T75","obj":"EnjuParser_T73"},{"id":"EnjuParser_R74","pred":"arg1Of","subj":"EnjuParser_T75","obj":"EnjuParser_T74"},{"id":"EnjuParser_R75","pred":"arg1Of","subj":"EnjuParser_T70","obj":"EnjuParser_T76"},{"id":"EnjuParser_R76","pred":"arg1Of","subj":"EnjuParser_T70","obj":"EnjuParser_T77"},{"id":"EnjuParser_R77","pred":"arg2Of","subj":"EnjuParser_T89","obj":"EnjuParser_T77"},{"id":"EnjuParser_R78","pred":"arg1Of","subj":"EnjuParser_T79","obj":"EnjuParser_T78"},{"id":"EnjuParser_R79","pred":"arg1Of","subj":"EnjuParser_T79","obj":"EnjuParser_T80"},{"id":"EnjuParser_R80","pred":"arg2Of","subj":"EnjuParser_T81","obj":"EnjuParser_T80"},{"id":"EnjuParser_R81","pred":"arg3Of","subj":"EnjuParser_T88","obj":"EnjuParser_T80"},{"id":"EnjuParser_R82","pred":"arg1Of","subj":"EnjuParser_T81","obj":"EnjuParser_T82"},{"id":"EnjuParser_R83","pred":"arg2Of","subj":"EnjuParser_T83","obj":"EnjuParser_T82"},{"id":"EnjuParser_R84","pred":"arg1Of","subj":"EnjuParser_T81","obj":"EnjuParser_T84"},{"id":"EnjuParser_R85","pred":"arg2Of","subj":"EnjuParser_T85","obj":"EnjuParser_T84"},{"id":"EnjuParser_R86","pred":"arg1Of","subj":"EnjuParser_T81","obj":"EnjuParser_T86"},{"id":"EnjuParser_R87","pred":"arg1Of","subj":"EnjuParser_T81","obj":"EnjuParser_T87"},{"id":"EnjuParser_R88","pred":"arg1Of","subj":"EnjuParser_T79","obj":"EnjuParser_T89"},{"id":"EnjuParser_R89","pred":"arg2Of","subj":"EnjuParser_T90","obj":"EnjuParser_T89"},{"id":"EnjuParser_R90","pred":"arg1Of","subj":"EnjuParser_T70","obj":"EnjuParser_T91"},{"id":"EnjuParser_R91","pred":"arg2Of","subj":"EnjuParser_T93","obj":"EnjuParser_T91"},{"id":"EnjuParser_R92","pred":"arg1Of","subj":"EnjuParser_T92","obj":"EnjuParser_T93"},{"id":"EnjuParser_R93","pred":"arg2Of","subj":"EnjuParser_T94","obj":"EnjuParser_T93"},{"id":"EnjuParser_R94","pred":"arg1Of","subj":"EnjuParser_T96","obj":"EnjuParser_T95"},{"id":"EnjuParser_R95","pred":"arg1Of","subj":"EnjuParser_T91","obj":"EnjuParser_T96"},{"id":"EnjuParser_R96","pred":"arg2Of","subj":"EnjuParser_T97","obj":"EnjuParser_T96"},{"id":"EnjuParser_R97","pred":"arg1Of","subj":"EnjuParser_T91","obj":"EnjuParser_T97"},{"id":"EnjuParser_R98","pred":"arg1Of","subj":"EnjuParser_T97","obj":"EnjuParser_T98"},{"id":"EnjuParser_R99","pred":"arg2Of","subj":"EnjuParser_T99","obj":"EnjuParser_T98"},{"id":"EnjuParser_R100","pred":"arg1Of","subj":"EnjuParser_T99","obj":"EnjuParser_T100"},{"id":"EnjuParser_R101","pred":"arg1Of","subj":"EnjuParser_T102","obj":"EnjuParser_T101"},{"id":"EnjuParser_R102","pred":"arg2Of","subj":"EnjuParser_T99","obj":"EnjuParser_T102"},{"id":"EnjuParser_R103","pred":"arg1Of","subj":"EnjuParser_T103","obj":"EnjuParser_T104"},{"id":"EnjuParser_R104","pred":"arg2Of","subj":"EnjuParser_T106","obj":"EnjuParser_T104"},{"id":"EnjuParser_R105","pred":"arg1Of","subj":"EnjuParser_T106","obj":"EnjuParser_T105"},{"id":"EnjuParser_R106","pred":"arg1Of","subj":"EnjuParser_T103","obj":"EnjuParser_T106"},{"id":"EnjuParser_R107","pred":"arg1Of","subj":"EnjuParser_T106","obj":"EnjuParser_T107"},{"id":"EnjuParser_R108","pred":"arg2Of","subj":"EnjuParser_T108","obj":"EnjuParser_T107"},{"id":"EnjuParser_R109","pred":"arg1Of","subj":"EnjuParser_T111","obj":"EnjuParser_T109"},{"id":"EnjuParser_R110","pred":"arg2Of","subj":"EnjuParser_T108","obj":"EnjuParser_T109"},{"id":"EnjuParser_R111","pred":"arg1Of","subj":"EnjuParser_T109","obj":"EnjuParser_T110"},{"id":"EnjuParser_R112","pred":"arg1Of","subj":"EnjuParser_T111","obj":"EnjuParser_T112"},{"id":"EnjuParser_R113","pred":"arg2Of","subj":"EnjuParser_T115","obj":"EnjuParser_T112"},{"id":"EnjuParser_R114","pred":"arg1Of","subj":"EnjuParser_T115","obj":"EnjuParser_T113"},{"id":"EnjuParser_R115","pred":"arg1Of","subj":"EnjuParser_T115","obj":"EnjuParser_T114"},{"id":"EnjuParser_R116","pred":"arg1Of","subj":"EnjuParser_T111","obj":"EnjuParser_T116"},{"id":"EnjuParser_R117","pred":"arg2Of","subj":"EnjuParser_T117","obj":"EnjuParser_T116"},{"id":"EnjuParser_R118","pred":"arg1Of","subj":"EnjuParser_T117","obj":"EnjuParser_T118"},{"id":"EnjuParser_R119","pred":"arg1Of","subj":"EnjuParser_T104","obj":"EnjuParser_T119"},{"id":"EnjuParser_R120","pred":"arg2Of","subj":"EnjuParser_T119","obj":"EnjuParser_T120"},{"id":"EnjuParser_R121","pred":"arg1Of","subj":"EnjuParser_T120","obj":"EnjuParser_T121"},{"id":"EnjuParser_R122","pred":"arg2Of","subj":"EnjuParser_T127","obj":"EnjuParser_T121"},{"id":"EnjuParser_R123","pred":"arg1Of","subj":"EnjuParser_T122","obj":"EnjuParser_T123"},{"id":"EnjuParser_R124","pred":"arg2Of","subj":"EnjuParser_T125","obj":"EnjuParser_T123"},{"id":"EnjuParser_R125","pred":"arg1Of","subj":"EnjuParser_T125","obj":"EnjuParser_T124"},{"id":"EnjuParser_R126","pred":"arg1Of","subj":"EnjuParser_T127","obj":"EnjuParser_T126"},{"id":"EnjuParser_R127","pred":"arg1Of","subj":"EnjuParser_T123","obj":"EnjuParser_T127"},{"id":"EnjuParser_R128","pred":"arg2Of","subj":"EnjuParser_T129","obj":"EnjuParser_T127"},{"id":"EnjuParser_R129","pred":"arg1Of","subj":"EnjuParser_T129","obj":"EnjuParser_T128"},{"id":"EnjuParser_R130","pred":"arg1Of","subj":"EnjuParser_T142","obj":"EnjuParser_T130"},{"id":"EnjuParser_R131","pred":"arg1Of","subj":"EnjuParser_T133","obj":"EnjuParser_T131"},{"id":"EnjuParser_R132","pred":"arg1Of","subj":"EnjuParser_T132","obj":"EnjuParser_T133"},{"id":"EnjuParser_R133","pred":"arg2Of","subj":"EnjuParser_T134","obj":"EnjuParser_T133"},{"id":"EnjuParser_R134","pred":"arg1Of","subj":"EnjuParser_T133","obj":"EnjuParser_T135"},{"id":"EnjuParser_R135","pred":"arg2Of","subj":"EnjuParser_T137","obj":"EnjuParser_T135"},{"id":"EnjuParser_R136","pred":"arg1Of","subj":"EnjuParser_T137","obj":"EnjuParser_T136"},{"id":"EnjuParser_R137","pred":"arg1Of","subj":"EnjuParser_T137","obj":"EnjuParser_T138"},{"id":"EnjuParser_R138","pred":"arg2Of","subj":"EnjuParser_T141","obj":"EnjuParser_T138"},{"id":"EnjuParser_R139","pred":"arg1Of","subj":"EnjuParser_T141","obj":"EnjuParser_T139"},{"id":"EnjuParser_R140","pred":"arg1Of","subj":"EnjuParser_T141","obj":"EnjuParser_T140"},{"id":"EnjuParser_R141","pred":"arg1Of","subj":"EnjuParser_T133","obj":"EnjuParser_T142"},{"id":"EnjuParser_R142","pred":"arg2Of","subj":"EnjuParser_T145","obj":"EnjuParser_T142"},{"id":"EnjuParser_R143","pred":"arg1Of","subj":"EnjuParser_T145","obj":"EnjuParser_T143"},{"id":"EnjuParser_R144","pred":"arg1Of","subj":"EnjuParser_T133","obj":"EnjuParser_T144"},{"id":"EnjuParser_R145","pred":"arg2Of","subj":"EnjuParser_T145","obj":"EnjuParser_T144"},{"id":"EnjuParser_R146","pred":"arg1Of","subj":"EnjuParser_T149","obj":"EnjuParser_T145"},{"id":"EnjuParser_R147","pred":"arg2Of","subj":"EnjuParser_T133","obj":"EnjuParser_T145"},{"id":"EnjuParser_R148","pred":"arg2Of","subj":"EnjuParser_T149","obj":"EnjuParser_T146"},{"id":"EnjuParser_R149","pred":"arg1Of","subj":"EnjuParser_T149","obj":"EnjuParser_T147"},{"id":"EnjuParser_R150","pred":"arg1Of","subj":"EnjuParser_T149","obj":"EnjuParser_T148"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-ArguminSci","denotations":[{"id":"T1","span":{"begin":0,"end":62},"obj":"DRI_Background"},{"id":"T2","span":{"begin":63,"end":229},"obj":"DRI_Background"},{"id":"T3","span":{"begin":230,"end":431},"obj":"DRI_Background"},{"id":"T4","span":{"begin":432,"end":559},"obj":"DRI_Background"},{"id":"T5","span":{"begin":559,"end":646},"obj":"DRI_Background"},{"id":"T6","span":{"begin":647,"end":831},"obj":"DRI_Background"},{"id":"T7","span":{"begin":832,"end":955},"obj":"DRI_Challenge"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-OGER","denotations":[{"id":"T1","span":{"begin":432,"end":447},"obj":"CHEBI:36044"},{"id":"T2","span":{"begin":508,"end":518},"obj":"CHEBI:35222"},{"id":"T3","span":{"begin":520,"end":531},"obj":"CHEBI:7798"},{"id":"T4","span":{"begin":544,"end":553},"obj":"CHEBI:50663"},{"id":"T5","span":{"begin":562,"end":573},"obj":"CHEBI:465284"},{"id":"T6","span":{"begin":575,"end":584},"obj":"CHEBI:2453"},{"id":"T7","span":{"begin":589,"end":598},"obj":"CHEBI:63580"},{"id":"T8","span":{"begin":711,"end":720},"obj":"CHEBI:31781"},{"id":"T9","span":{"begin":723,"end":732},"obj":"CHEBI:45409"},{"id":"T10","span":{"begin":734,"end":743},"obj":"CHEBI:31781"},{"id":"T11","span":{"begin":746,"end":755},"obj":"CHEBI:45409"},{"id":"T1","span":{"begin":820,"end":830},"obj":"GO:0042571"},{"id":"T1","span":{"begin":361,"end":365},"obj":"PR:000014459"},{"id":"T2","span":{"begin":770,"end":782},"obj":"PR:000024939"},{"id":"T1","span":{"begin":600,"end":603},"obj":"SO:0001853"},{"id":"T2","span":{"begin":653,"end":656},"obj":"SO:0001853"},{"id":"T3","span":{"begin":916,"end":918},"obj":"SO:0000999"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PubTatorCentral","denotations":[{"id":"T1","span":{"begin":86,"end":105},"obj":"Disease:MESH:D012131"},{"id":"T2","span":{"begin":314,"end":359},"obj":"Species:227859"},{"id":"T3","span":{"begin":361,"end":369},"obj":"Species:227859"},{"id":"T4","span":{"begin":375,"end":419},"obj":"Disease:MESH:D018352"},{"id":"T5","span":{"begin":421,"end":429},"obj":"Disease:MESH:D018352"},{"id":"T6","span":{"begin":520,"end":531},"obj":"Chemical:MESH:D053139"},{"id":"T7","span":{"begin":533,"end":542},"obj":"Chemical:"},{"id":"T8","span":{"begin":544,"end":553},"obj":"Chemical:MESH:D053243"},{"id":"T9","span":{"begin":562,"end":573},"obj":"Chemical:MESH:D015774"},{"id":"T10","span":{"begin":575,"end":584},"obj":"Chemical:MESH:D000212"},{"id":"T11","span":{"begin":589,"end":598},"obj":"Chemical:MESH:D012254"},{"id":"T12","span":{"begin":711,"end":720},"obj":"Chemical:MESH:D061466"},{"id":"T13","span":{"begin":723,"end":732},"obj":"Chemical:MESH:D019438"},{"id":"T14","span":{"begin":734,"end":743},"obj":"Chemical:MESH:D061466"},{"id":"T15","span":{"begin":746,"end":755},"obj":"Chemical:MESH:D019438"},{"id":"T16","span":{"begin":889,"end":898},"obj":"Disease:MESH:D011014"},{"id":"T17","span":{"begin":899,"end":907},"obj":"Species:9606"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":62},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":63,"end":229},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":230,"end":431},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":432,"end":646},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":647,"end":831},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":832,"end":955},"obj":"Sentence"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok1","span":{"begin":0,"end":1},"obj":"NN"},{"id":"tok2","span":{"begin":1,"end":10},"obj":"JJ"},{"id":"tok3","span":{"begin":11,"end":20},"obj":"JJ"},{"id":"tok4","span":{"begin":21,"end":33},"obj":"NNS"},{"id":"tok5","span":{"begin":34,"end":37},"obj":"IN"},{"id":"tok6","span":{"begin":38,"end":42},"obj":"CD"},{"id":"tok7","span":{"begin":43,"end":48},"obj":"NNP"},{"id":"tok8","span":{"begin":49,"end":60},"obj":"NNP"},{"id":"tok9","span":{"begin":60,"end":61},"obj":"NN"},{"id":"tok10","span":{"begin":61,"end":62},"obj":"."},{"id":"tok11","span":{"begin":63,"end":66},"obj":"DT"},{"id":"tok12","span":{"begin":67,"end":73},"obj":"JJ"},{"id":"tok13","span":{"begin":74,"end":82},"obj":"NN"},{"id":"tok14","span":{"begin":83,"end":85},"obj":"IN"},{"id":"tok15","span":{"begin":86,"end":97},"obj":"JJ"},{"id":"tok16","span":{"begin":98,"end":105},"obj":"NN"},{"id":"tok17","span":{"begin":106,"end":108},"obj":"IN"},{"id":"tok18","span":{"begin":109,"end":114},"obj":"NNP"},{"id":"tok19","span":{"begin":114,"end":115},"obj":","},{"id":"tok20","span":{"begin":116,"end":121},"obj":"NNP"},{"id":"tok21","span":{"begin":122,"end":124},"obj":"VBZ"},{"id":"tok22","span":{"begin":125,"end":131},"obj":"VBN"},{"id":"tok23","span":{"begin":132,"end":134},"obj":"IN"},{"id":"tok24","span":{"begin":135,"end":136},"obj":"DT"},{"id":"tok25","span":{"begin":137,"end":142},"obj":"NN"},{"id":"tok26","span":{"begin":143,"end":154},"obj":"JJ"},{"id":"tok27","span":{"begin":154,"end":155},"obj":","},{"id":"tok28","span":{"begin":156,"end":161},"obj":"VBD"},{"id":"tok29","span":{"begin":162,"end":166},"obj":"CD"},{"id":"tok30","span":{"begin":166,"end":167},"obj":":"},{"id":"tok31","span":{"begin":167,"end":171},"obj":"NN"},{"id":"tok32","span":{"begin":171,"end":172},"obj":","},{"id":"tok33","span":{"begin":173,"end":178},"obj":"WDT"},{"id":"tok34","span":{"begin":179,"end":181},"obj":"VBZ"},{"id":"tok35","span":{"begin":182,"end":193},"obj":"RB"},{"id":"tok36","span":{"begin":194,"end":199},"obj":"RB"},{"id":"tok37","span":{"begin":200,"end":202},"obj":"TO"},{"id":"tok38","span":{"begin":203,"end":204},"obj":"DT"},{"id":"tok39","span":{"begin":205,"end":216},"obj":"JJ"},{"id":"tok40","span":{"begin":217,"end":228},"obj":"JJ"},{"id":"tok41","span":{"begin":228,"end":229},"obj":"."},{"id":"tok42","span":{"begin":230,"end":234},"obj":"CD"},{"id":"tok43","span":{"begin":234,"end":235},"obj":":"},{"id":"tok44","span":{"begin":235,"end":239},"obj":"NN"},{"id":"tok45","span":{"begin":240,"end":242},"obj":"VBZ"},{"id":"tok46","span":{"begin":243,"end":254},"obj":"VBN"},{"id":"tok47","span":{"begin":255,"end":257},"obj":"IN"},{"id":"tok48","span":{"begin":258,"end":262},"obj":"NN"},{"id":"tok49","span":{"begin":263,"end":268},"obj":"JJ"},{"id":"tok50","span":{"begin":269,"end":280},"obj":"JJ"},{"id":"tok51","span":{"begin":280,"end":281},"obj":","},{"id":"tok52","span":{"begin":282,"end":286},"obj":"JJ"},{"id":"tok53","span":{"begin":287,"end":289},"obj":"IN"},{"id":"tok54","span":{"begin":290,"end":293},"obj":"DT"},{"id":"tok55","span":{"begin":294,"end":297},"obj":"CD"},{"id":"tok56","span":{"begin":298,"end":303},"obj":"JJ"},{"id":"tok57","span":{"begin":304,"end":311},"obj":"NNS"},{"id":"tok58","span":{"begin":312,"end":313},"obj":":"},{"id":"tok59","span":{"begin":314,"end":320},"obj":"JJ"},{"id":"tok60","span":{"begin":321,"end":326},"obj":"JJ"},{"id":"tok61","span":{"begin":327,"end":338},"obj":"JJ"},{"id":"tok62","span":{"begin":339,"end":347},"obj":"NN"},{"id":"tok63","span":{"begin":348,"end":359},"obj":"JJ"},{"id":"tok64","span":{"begin":360,"end":361},"obj":"("},{"id":"tok65","span":{"begin":361,"end":369},"obj":"NNP"},{"id":"tok66","span":{"begin":369,"end":370},"obj":")"},{"id":"tok67","span":{"begin":371,"end":374},"obj":"CC"},{"id":"tok68","span":{"begin":375,"end":381},"obj":"NNP"},{"id":"tok69","span":{"begin":382,"end":386},"obj":"NNP"},{"id":"tok70","span":{"begin":387,"end":398},"obj":"JJ"},{"id":"tok71","span":{"begin":399,"end":407},"obj":"NN"},{"id":"tok72","span":{"begin":408,"end":419},"obj":"JJ"},{"id":"tok73","span":{"begin":420,"end":421},"obj":"("},{"id":"tok74","span":{"begin":421,"end":429},"obj":"NNP"},{"id":"tok75","span":{"begin":429,"end":430},"obj":")"},{"id":"tok76","span":{"begin":430,"end":431},"obj":"."},{"id":"tok77","span":{"begin":432,"end":441},"obj":"NNP"},{"id":"tok78","span":{"begin":442,"end":447},"obj":"NNS"},{"id":"tok79","span":{"begin":448,"end":456},"obj":"RB"},{"id":"tok80","span":{"begin":457,"end":461},"obj":"VBN"},{"id":"tok81","span":{"begin":462,"end":464},"obj":"IN"},{"id":"tok82","span":{"begin":465,"end":473},"obj":"JJ"},{"id":"tok83","span":{"begin":474,"end":482},"obj":"NN"},{"id":"tok84","span":{"begin":482,"end":483},"obj":","},{"id":"tok85","span":{"begin":484,"end":493},"obj":"VBG"},{"id":"tok86","span":{"begin":494,"end":507},"obj":"NN"},{"id":"tok87","span":{"begin":508,"end":518},"obj":"NNS"},{"id":"tok88","span":{"begin":519,"end":520},"obj":"("},{"id":"tok89","span":{"begin":520,"end":531},"obj":"NN"},{"id":"tok90","span":{"begin":531,"end":532},"obj":","},{"id":"tok91","span":{"begin":533,"end":542},"obj":"NN"},{"id":"tok92","span":{"begin":542,"end":543},"obj":","},{"id":"tok93","span":{"begin":544,"end":553},"obj":"NN"},{"id":"tok94","span":{"begin":553,"end":554},"obj":","},{"id":"tok95","span":{"begin":555,"end":558},"obj":"FW"},{"id":"tok96","span":{"begin":558,"end":559},"obj":"."},{"id":"tok97","span":{"begin":559,"end":560},"obj":")"},{"id":"tok98","span":{"begin":560,"end":561},"obj":","},{"id":"tok99","span":{"begin":562,"end":573},"obj":"NN"},{"id":"tok100","span":{"begin":573,"end":574},"obj":","},{"id":"tok101","span":{"begin":575,"end":584},"obj":"NN"},{"id":"tok102","span":{"begin":585,"end":588},"obj":"CC"},{"id":"tok103","span":{"begin":589,"end":598},"obj":"NN"},{"id":"tok104","span":{"begin":598,"end":599},"obj":","},{"id":"tok105","span":{"begin":600,"end":603},"obj":"VBP"},{"id":"tok106","span":{"begin":604,"end":611},"obj":"JJ"},{"id":"tok107","span":{"begin":612,"end":615},"obj":"IN"},{"id":"tok108","span":{"begin":616,"end":620},"obj":"CD"},{"id":"tok109","span":{"begin":620,"end":621},"obj":":"},{"id":"tok110","span":{"begin":621,"end":625},"obj":"NN"},{"id":"tok111","span":{"begin":626,"end":629},"obj":"CC"},{"id":"tok112","span":{"begin":630,"end":633},"obj":"RB"},{"id":"tok113","span":{"begin":634,"end":645},"obj":"VBD"},{"id":"tok114","span":{"begin":645,"end":646},"obj":"."},{"id":"tok115","span":{"begin":647,"end":652},"obj":"NNS"},{"id":"tok116","span":{"begin":653,"end":656},"obj":"VBP"},{"id":"tok117","span":{"begin":657,"end":665},"obj":"RB"},{"id":"tok118","span":{"begin":666,"end":675},"obj":"JJ"},{"id":"tok119","span":{"begin":676,"end":679},"obj":"IN"},{"id":"tok120","span":{"begin":680,"end":684},"obj":"CD"},{"id":"tok121","span":{"begin":684,"end":685},"obj":":"},{"id":"tok122","span":{"begin":685,"end":689},"obj":"NN"},{"id":"tok123","span":{"begin":690,"end":697},"obj":"VBP"},{"id":"tok124","span":{"begin":697,"end":698},"obj":":"},{"id":"tok125","span":{"begin":699,"end":709},"obj":"NN"},{"id":"tok126","span":{"begin":709,"end":710},"obj":","},{"id":"tok127","span":{"begin":711,"end":720},"obj":"NN"},{"id":"tok128","span":{"begin":721,"end":722},"obj":"NN"},{"id":"tok129","span":{"begin":723,"end":732},"obj":"NN"},{"id":"tok130","span":{"begin":732,"end":733},"obj":","},{"id":"tok131","span":{"begin":734,"end":743},"obj":"NN"},{"id":"tok132","span":{"begin":744,"end":745},"obj":"NN"},{"id":"tok133","span":{"begin":746,"end":755},"obj":"NN"},{"id":"tok134","span":{"begin":756,"end":764},"obj":"VBN"},{"id":"tok135","span":{"begin":765,"end":769},"obj":"IN"},{"id":"tok136","span":{"begin":770,"end":782},"obj":"JJ"},{"id":"tok137","span":{"begin":782,"end":783},"obj":","},{"id":"tok138","span":{"begin":784,"end":796},"obj":"NN"},{"id":"tok139","span":{"begin":797,"end":803},"obj":"NN"},{"id":"tok140","span":{"begin":803,"end":804},"obj":","},{"id":"tok141","span":{"begin":805,"end":808},"obj":"CC"},{"id":"tok142","span":{"begin":809,"end":819},"obj":"NN"},{"id":"tok143","span":{"begin":820,"end":830},"obj":"NNS"},{"id":"tok144","span":{"begin":830,"end":831},"obj":"."},{"id":"tok145","span":{"begin":832,"end":835},"obj":"CC"},{"id":"tok146","span":{"begin":836,"end":839},"obj":"DT"},{"id":"tok147","span":{"begin":840,"end":848},"obj":"NN"},{"id":"tok148","span":{"begin":849,"end":852},"obj":"CC"},{"id":"tok149","span":{"begin":853,"end":859},"obj":"NN"},{"id":"tok150","span":{"begin":860,"end":862},"obj":"IN"},{"id":"tok151","span":{"begin":863,"end":868},"obj":"DT"},{"id":"tok152","span":{"begin":869,"end":874},"obj":"NNS"},{"id":"tok153","span":{"begin":875,"end":878},"obj":"IN"},{"id":"tok154","span":{"begin":879,"end":883},"obj":"CD"},{"id":"tok155","span":{"begin":883,"end":884},"obj":":"},{"id":"tok156","span":{"begin":884,"end":888},"obj":"NN"},{"id":"tok157","span":{"begin":889,"end":898},"obj":"NN"},{"id":"tok158","span":{"begin":899,"end":907},"obj":"NNS"},{"id":"tok159","span":{"begin":908,"end":912},"obj":"VBP"},{"id":"tok160","span":{"begin":913,"end":915},"obj":"TO"},{"id":"tok161","span":{"begin":916,"end":918},"obj":"VB"},{"id":"tok162","span":{"begin":919,"end":927},"obj":"VBN"},{"id":"tok163","span":{"begin":928,"end":930},"obj":"IN"},{"id":"tok164","span":{"begin":931,"end":938},"obj":"JJ"},{"id":"tok165","span":{"begin":939,"end":947},"obj":"JJ"},{"id":"tok166","span":{"begin":948,"end":954},"obj":"NNS"},{"id":"tok167","span":{"begin":954,"end":955},"obj":"."},{"id":"lookup1","span":{"begin":38,"end":42},"obj":"year"},{"id":"lookup2","span":{"begin":106,"end":108},"obj":"country_code"},{"id":"lookup3","span":{"begin":109,"end":114},"obj":"location"},{"id":"lookup4","span":{"begin":116,"end":121},"obj":"location"},{"id":"lookup5","span":{"begin":122,"end":124},"obj":"country_code"},{"id":"lookup6","span":{"begin":132,"end":134},"obj":"country_code"},{"id":"lookup7","span":{"begin":162,"end":166},"obj":"year"},{"id":"lookup8","span":{"begin":179,"end":181},"obj":"country_code"},{"id":"lookup9","span":{"begin":200,"end":202},"obj":"country_code"},{"id":"lookup10","span":{"begin":230,"end":234},"obj":"year"},{"id":"lookup11","span":{"begin":240,"end":242},"obj":"country_code"},{"id":"lookup12","span":{"begin":255,"end":257},"obj":"country_code"},{"id":"lookup13","span":{"begin":258,"end":262},"obj":"person_first"},{"id":"lookup14","span":{"begin":287,"end":289},"obj":"country_code"},{"id":"lookup15","span":{"begin":294,"end":297},"obj":"time"},{"id":"lookup16","span":{"begin":294,"end":297},"obj":"number"},{"id":"lookup17","span":{"begin":375,"end":386},"obj":"location"},{"id":"lookup18","span":{"begin":382,"end":386},"obj":"loc_key"},{"id":"lookup19","span":{"begin":462,"end":464},"obj":"country_code"},{"id":"lookup20","span":{"begin":616,"end":620},"obj":"year"},{"id":"lookup21","span":{"begin":680,"end":684},"obj":"year"},{"id":"lookup22","span":{"begin":879,"end":883},"obj":"year"},{"id":"lookup23","span":{"begin":913,"end":915},"obj":"country_code"},{"id":"lookup24","span":{"begin":916,"end":918},"obj":"country_code"},{"id":"lookup25","span":{"begin":928,"end":930},"obj":"country_code"},{"id":"event1","span":{"begin":908,"end":912},"obj":"OCCURRENCE"},{"id":"event2","span":{"begin":919,"end":927},"obj":"OCCURRENCE"},{"id":"event3","span":{"begin":156,"end":161},"obj":"OCCURRENCE"},{"id":"event4","span":{"begin":756,"end":764},"obj":"OCCURRENCE"},{"id":"event5","span":{"begin":125,"end":131},"obj":"OCCURRENCE"},{"id":"event6","span":{"begin":457,"end":461},"obj":"OCCURRENCE"},{"id":"event7","span":{"begin":243,"end":254},"obj":"OCCURRENCE"},{"id":"event8","span":{"begin":634,"end":645},"obj":"OCCURRENCE"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T1","span":{"begin":314,"end":347},"obj":"Disease"},{"id":"T2","span":{"begin":361,"end":369},"obj":"Disease"},{"id":"T3","span":{"begin":889,"end":898},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PD-HP-v1","denotations":[{"id":"T1","span":{"begin":889,"end":898},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PD-FMA-UBERON-v1","denotations":[{"id":"T1","span":{"begin":797,"end":803},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":797,"end":803},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":314,"end":347},"obj":"Disease"},{"id":"T2","span":{"begin":361,"end":369},"obj":"Disease"},{"id":"T3","span":{"begin":889,"end":898},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":135,"end":136},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":203,"end":204},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T3","span":{"begin":205,"end":208},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9397"},{"id":"T4","span":{"begin":797,"end":803},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":11,"end":20},"obj":"Chemical"},{"id":"T2","span":{"begin":258,"end":262},"obj":"Chemical"},{"id":"T3","span":{"begin":442,"end":447},"obj":"Chemical"},{"id":"T4","span":{"begin":494,"end":518},"obj":"Chemical"},{"id":"T5","span":{"begin":508,"end":518},"obj":"Chemical"},{"id":"T6","span":{"begin":520,"end":531},"obj":"Chemical"},{"id":"T7","span":{"begin":544,"end":553},"obj":"Chemical"},{"id":"T8","span":{"begin":562,"end":573},"obj":"Chemical"},{"id":"T9","span":{"begin":575,"end":584},"obj":"Chemical"},{"id":"T10","span":{"begin":589,"end":598},"obj":"Chemical"},{"id":"T11","span":{"begin":699,"end":709},"obj":"Chemical"},{"id":"T12","span":{"begin":711,"end":720},"obj":"Chemical"},{"id":"T13","span":{"begin":723,"end":732},"obj":"Chemical"},{"id":"T14","span":{"begin":734,"end":743},"obj":"Chemical"},{"id":"T15","span":{"begin":746,"end":755},"obj":"Chemical"},{"id":"T16","span":{"begin":770,"end":780},"obj":"Chemical"},{"id":"T17","span":{"begin":869,"end":874},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_10545"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_52425"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_50663"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_465284"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_2453"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_63580"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1","span":{"begin":38,"end":60},"obj":"Species"},{"id":"25","span":{"begin":86,"end":105},"obj":"Disease"},{"id":"26","span":{"begin":137,"end":154},"obj":"Species"},{"id":"27","span":{"begin":162,"end":171},"obj":"Species"},{"id":"28","span":{"begin":217,"end":239},"obj":"Species"},{"id":"29","span":{"begin":269,"end":280},"obj":"Species"},{"id":"30","span":{"begin":314,"end":359},"obj":"Species"},{"id":"31","span":{"begin":361,"end":369},"obj":"Species"},{"id":"32","span":{"begin":408,"end":419},"obj":"Species"},{"id":"33","span":{"begin":494,"end":507},"obj":"Gene"},{"id":"34","span":{"begin":520,"end":531},"obj":"Chemical"},{"id":"35","span":{"begin":533,"end":542},"obj":"Chemical"},{"id":"36","span":{"begin":544,"end":553},"obj":"Chemical"},{"id":"37","span":{"begin":562,"end":573},"obj":"Chemical"},{"id":"38","span":{"begin":575,"end":584},"obj":"Chemical"},{"id":"39","span":{"begin":589,"end":598},"obj":"Chemical"},{"id":"40","span":{"begin":616,"end":625},"obj":"Species"},{"id":"41","span":{"begin":680,"end":689},"obj":"Species"},{"id":"42","span":{"begin":699,"end":709},"obj":"Chemical"},{"id":"43","span":{"begin":711,"end":732},"obj":"Chemical"},{"id":"44","span":{"begin":734,"end":755},"obj":"Chemical"},{"id":"45","span":{"begin":770,"end":782},"obj":"Gene"},{"id":"46","span":{"begin":879,"end":898},"obj":"Disease"},{"id":"47","span":{"begin":899,"end":907},"obj":"Species"}],"attributes":[{"id":"A1","pred":"tao:has_database_id","subj":"1","obj":"Tax:2697049"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"MESH:D012140"},{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"Tax:2697049"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Tax:2697049"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"Tax:2697049"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Tax:11118"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Tax:694009"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Tax:694009"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:11118"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Gene:4758"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:D053139"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:D053243"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:D015774"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:D000212"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"MESH:D012254"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"Tax:2697049"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Tax:2697049"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:C000606551"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:C558899"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:C558899"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Gene:3456"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:C000657245"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":86,"end":105},"obj":"Phenotype"},{"id":"T2","span":{"begin":889,"end":898},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002086"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid_AGAC_only","denotations":[{"id":"p107s4","span":{"begin":86,"end":105},"obj":"Disease"},{"id":"p107s11","span":{"begin":125,"end":134},"obj":"Reg"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":62},"obj":"Sentence"},{"id":"T2","span":{"begin":63,"end":229},"obj":"Sentence"},{"id":"T3","span":{"begin":230,"end":431},"obj":"Sentence"},{"id":"T4","span":{"begin":432,"end":646},"obj":"Sentence"},{"id":"T5","span":{"begin":647,"end":831},"obj":"Sentence"},{"id":"T6","span":{"begin":832,"end":955},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"[Potential antiviral therapeutics for 2019 Novel Coronavirus].\nThe recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials."}